Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Gallagher

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Annals of Surgical Oncology|February 19, 2009
Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastasesDavid J Gallagher, Junting Zheng, Marinela Capanu, et al.
Irish Journal of Medical Science|October 19, 2022
Uptake of BRCA1/BRCA2 predictive genetic testing in an Irish population is low: a missed opportunityDavid E O'Reilly, Lucy Dooley, Geoffrey A Watson, et al.
Cancer|August 12, 2009
Sequential adjuvant chemotherapy after surgical resection of high-risk urothelial carcinomaDavid J Gallagher, Matthew I Milowsky, Alexia Iasonos, et al.
Genes, Chromosomes & Cancer|April 6, 2021
Insertion of an SVA element in MSH2 as a novel cause of Lynch syndromeCiyu Yang, Yirong Li, Magan Trottier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2013
Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancerArjun V Balar, Andrea B Apolo, Irina Ostrovnaya, et al.
BJU International|August 17, 2010
Hypoxia-inducible factor and mammalian target of rapamycin pathway markers in urothelial carcinoma of the bladder: possible therapeutic implicationsSatish K Tickoo, Matthew I Milowsky, Nitin Dhar, et al.
European Urology|June 8, 2011
Sunitinib in urothelial cancer: clinical, pharmacokinetic, and immunohistochemical study of predictors of responseDavid J Gallagher, Hikmat Al-Ahmadie, Irina Ostrovnaya, et al.
Cancer Epidemiology|August 8, 2017
High-risk family colorectal cancer screening service in Ireland: Critical review of clinical outcomesMargaret Walshe, Robert Moran, Marie Boyle, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 7, 2022
Extramural venous invasion (EMVI) in colorectal cancer is associated with increased cancer recurrence and cancer-related deathPhilip D Mc Entee, Poorya Shokuhi, Ailin C Rogers, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 29, 2025
Immunotherapy for downstaging of locally advanced mismatch repair deficient colorectal cancer: A prospective institutional case seriesMaeve A O'Neill, Emily C Harrold, Charles Gillham, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Annals of Surgical Oncology|February 19, 2009
Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastasesDavid J Gallagher, Junting Zheng, Marinela Capanu, et al.
Irish Journal of Medical Science|October 19, 2022
Uptake of BRCA1/BRCA2 predictive genetic testing in an Irish population is low: a missed opportunityDavid E O'Reilly, Lucy Dooley, Geoffrey A Watson, et al.
Cancer|August 12, 2009
Sequential adjuvant chemotherapy after surgical resection of high-risk urothelial carcinomaDavid J Gallagher, Matthew I Milowsky, Alexia Iasonos, et al.
Genes, Chromosomes & Cancer|April 6, 2021
Insertion of an SVA element in MSH2 as a novel cause of Lynch syndromeCiyu Yang, Yirong Li, Magan Trottier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2013
Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancerArjun V Balar, Andrea B Apolo, Irina Ostrovnaya, et al.
BJU International|August 17, 2010
Hypoxia-inducible factor and mammalian target of rapamycin pathway markers in urothelial carcinoma of the bladder: possible therapeutic implicationsSatish K Tickoo, Matthew I Milowsky, Nitin Dhar, et al.
European Urology|June 8, 2011
Sunitinib in urothelial cancer: clinical, pharmacokinetic, and immunohistochemical study of predictors of responseDavid J Gallagher, Hikmat Al-Ahmadie, Irina Ostrovnaya, et al.
Cancer Epidemiology|August 8, 2017
High-risk family colorectal cancer screening service in Ireland: Critical review of clinical outcomesMargaret Walshe, Robert Moran, Marie Boyle, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 7, 2022
Extramural venous invasion (EMVI) in colorectal cancer is associated with increased cancer recurrence and cancer-related deathPhilip D Mc Entee, Poorya Shokuhi, Ailin C Rogers, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 29, 2025
Immunotherapy for downstaging of locally advanced mismatch repair deficient colorectal cancer: A prospective institutional case seriesMaeve A O'Neill, Emily C Harrold, Charles Gillham, et al.
Pageof 4